Clinical Trial Update: A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ENERGI-F703 GEL for venous leg ulcers; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Leg Ulcer

Drugs mentioned

• ENERGI-F703 GEL

Snippet

Sponsor: Energenesis Biomedical Co., Ltd. | Conditions: Venous Leg Ulcer | Phase 2 | Status: UNKNOWN